Azoospermia is the complete absence of sperm in the ejaculate, confirmed on two separate centrifuged semen samples. It is found in approximately 1% of the general male population and in roughly 10–15% of men presenting with infertility (Jarow et al., Journal of Urology; ASRM Practice Committee guidance in Fertility and Sterility). Modern reproductive medicine allows most of these men to achieve biological fatherhood when evaluated and treated correctly.
Azoospermia expertise with Dr. Arun Muthuvel in Chennai
Dr. Arun Muthuvel is an MCh-qualified reproductive medicine and surgery specialist in Chennai who manages the full azoospermia pathway: diagnosis, genetic assessment, microsurgical reconstruction, surgical sperm retrieval including micro-TESE, and IVF-ICSI.
The most important step is separating obstructive from non-obstructive azoospermia, because the two have entirely different treatments and outcomes. Dr. Arun Muthuvel makes that distinction with examination, hormone tests and genetics rather than proceeding directly to surgery, and a diagnostic biopsy is rarely necessary.
Two Major Categories
Clinically, azoospermia is divided into two groups, each with distinct causes and treatment pathways:
- Obstructive azoospermia (OA): Normal sperm production, but a blockage prevents sperm from reaching the ejaculate. Accounts for roughly 40% of cases.
- Non-obstructive azoospermia (NOA): Impaired or absent sperm production within the testis. Accounts for roughly 60% of cases and is the more challenging form to treat.
Causes
Obstructive: vasectomy, congenital bilateral absence of the vas deferens (often associated with CFTR mutations), infections of the epididymis, iatrogenic injury, or ejaculatory duct obstruction.
Non-obstructive: genetic causes such as Klinefelter syndrome (47,XXY) and Y-chromosome microdeletions (AZFa, AZFb, AZFc), cryptorchidism, prior chemotherapy or radiotherapy, testicular torsion, mumps orchitis, hypogonadotropic hypogonadism, or idiopathic in many cases. Reviews in Human Reproduction Update and Fertility and Sterility have repeatedly highlighted the importance of genetic workup before treatment.
Diagnostic Evaluation
- History and examination: Pubertal development, prior surgeries, infections, medication, testicular volume, presence or absence of the vas deferens.
- Repeat semen analysis with centrifugation, performed according to the WHO 6th edition laboratory manual.
- Hormone profile: FSH, LH, testosterone, and prolactin. Elevated FSH with small testes suggests NOA; normal FSH and volume typically suggest OA.
- Genetic testing: Karyotype, Y-chromosome microdeletion analysis, and CFTR mutation screening where appropriate.
- Scrotal and transrectal ultrasound: To detect varicocele, epididymal dilation, or ejaculatory duct obstruction.
Treatment of Obstructive Azoospermia
Reconstructive microsurgery (vasovasostomy or vasoepididymostomy) can restore natural fertility in selected men. When reconstruction is not feasible or unsuccessful, surgical sperm retrieval techniques such as PESA (percutaneous epididymal sperm aspiration), MESA (microsurgical epididymal sperm aspiration), or TESA (testicular sperm aspiration) combined with IVF/ICSI are highly successful. Sperm retrieval rates exceed 90% in OA cases.
Treatment of Non-Obstructive Azoospermia
For NOA, microdissection testicular sperm extraction (micro-TESE), first described by Schlegel (Human Reproduction, 1999), is now considered the gold standard. It achieves sperm retrieval in approximately 40–60% of men with NOA, depending on the underlying cause, while removing significantly less testicular tissue than conventional TESE. Retrieved sperm are used immediately or cryopreserved for ICSI. In men with hypogonadotropic hypogonadism, gonadotropin therapy can often restore spermatogenesis without surgery.
Genetic Counselling
Because certain genetic abnormalities such as Y-chromosome microdeletions are heritable, and Klinefelter syndrome and CFTR mutations carry specific reproductive implications, genetic counselling is an essential part of the care pathway for any man with azoospermia before initiating treatment.
Confirming the Diagnosis
Azoospermia means no sperm are found in the ejaculate. The diagnosis requires at least two separate samples, each centrifuged and the pellet examined, because a small number of sperm are sometimes found this way and change the plan entirely.
A low semen volume with azoospermia suggests ejaculatory duct obstruction, absent vas deferens or retrograde ejaculation, and a post-ejaculatory urine sample should be examined before anything else is done.
Distinguishing the Two Types
| Feature | Obstructive | Non-obstructive |
|---|---|---|
| Testicular volume | Normal | Often reduced |
| FSH | Normal or low | Usually raised |
| Epididymis | Often full or firm | Normal or flat |
| Vas deferens | May be absent in CBAVD | Present |
| Sperm production | Normal | Impaired or absent |
| Sperm retrieval success | Over 90 percent | Roughly 40 to 60 percent with micro-TESE |
| Main treatments | Reconstruction, or PESA, TESA, TESE with ICSI | Micro-TESE with ICSI; hormonal treatment in selected men |
Genetic Testing Before Treatment
- Karyotype: Klinefelter syndrome is the commonest chromosomal cause of non-obstructive azoospermia, and sperm can still be retrieved in a proportion of men
- Y-chromosome microdeletion: complete AZFa or AZFb deletion means retrieval will not succeed, and this knowledge prevents futile surgery
- CFTR mutation testing: essential when the vas deferens is absent, since the female partner must also be tested before ICSI
- Counselling: some causes are heritable and this must be discussed before treatment
Treatment Pathways
In obstructive azoospermia, microsurgical reconstruction can restore sperm to the ejaculate in suitable men, allowing natural conception. Where reconstruction is not possible, sperm are retrieved by TESA or TESE and used for ICSI. Read more in our guide to obstructive azoospermia.
In non-obstructive azoospermia, micro-TESE is the recommended retrieval technique because it identifies the small areas of active sperm production under an operating microscope. Sperm mapping can help predict and target retrieval in selected men, and hormonal optimisation is used beforehand in men with low testosterone or raised oestradiol.
Frequently Asked Questions
Does azoospermia mean I can never father a child?
In most cases no. Sperm are retrievable in over 90 percent of men with obstruction and in roughly half of men with non-obstructive azoospermia, and can then be used for ICSI.
Do I need a testicular biopsy to find out which type I have?
Usually not. Examination, testicular volume, FSH and genetic testing distinguish the two types in most men, and surgery is planned directly as the appropriate retrieval procedure.
Can medication restore sperm production?
In men with low gonadotrophins, hormonal treatment can be very effective. In most other forms of non-obstructive azoospermia, medication may optimise conditions before retrieval but rarely restores sperm to the ejaculate.
Is azoospermia inherited?
Some causes are, including Y-chromosome microdeletions passed to sons and CFTR mutations. This is why genetic testing and counselling precede treatment.
Why consult Dr. Arun Muthuvel for azoospermia in Chennai?
His MCh training covers diagnosis, genetics, microsurgical reconstruction, micro-TESE and IVF-ICSI, so the whole pathway is managed by one specialist and futile surgery is avoided.
The Bottom Line
Azoospermia is not the end of the road: the priority is distinguishing obstruction from impaired production, because that determines whether reconstruction, simple retrieval or micro-TESE is the right route. Dr. Arun Muthuvel provides complete azoospermia evaluation and treatment in Chennai.
This article provides general medical information and does not replace individual diagnosis or treatment advice. Outcomes vary with age, diagnosis, test results and clinical circumstances.